Where does The Council of the Queensland Institute of Medical Research rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), The Council of the Queensland Institute of Medical Research ranks #23,523 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is The Council of the Queensland Institute of Medical Research's patent grant rate increasing or decreasing?

The Council of the Queensland Institute of Medical Research's recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for The Council of the Queensland Institute of Medical Research's patents?

The Council of the Queensland Institute of Medical Research's patents average 18.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

The Council of the Queensland Institute of Medical Research

Q: How is the The Council of the Queensland Institute of Medical Research patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 12 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, The ranks #23,523 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 11 technology areas.

#23,523
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.5/100): 18.1
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23523 · Foreign Corporation #23,523 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,523/49,997
PHOTO-FINISH Tektronix Texas
CPC-FOCUS C12N · 11 areas
INNOV-PAR 42.5/100
CLAIMS-RICH 18.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tektronix Texas, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How The’s 42.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (21%) Velocity 11.1 pts (26%) Breadth 11.7 pts (28%) Claim depth 10.8 pts (25%)

Qualcomm Incorporated · highest

85
The Council of the… · this assignee

43
3D Lighting… · lowest

7

What this shows The's Innovation Score is 42.5/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for The?

Each dot is one of The’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). The’s own 18.1 claims/patent is ABOVE the 16.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

The vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where The's grants concentrate

The Council of the Queensland Institute of Medical Research is a focused PatentsView assignee: 11 CPC subclasses with 75% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2015. By volume, The sits between Tektronix Texas, LLC and The Hive Global Inc..

The's three-year grant acceleration

The Council of the Queensland Institute of Medical Research shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Tektronix Texas

12
Tetraphase Pharma…

12
Texas Fueling Ser…

12
The Board of Trus…

12
The Ford Meter Box

12
The Gravity Group

12
The Hilliard

12
The Hive Global

12
The Council of th… ◀

12

What this shows The holds 12 patents at rank #23,540, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near The

By rank, the assignees closest to #23,540 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in The's primary technology class.

The's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

The Council of the Queensland Institute of Medical Research patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	8.3%
2018	1	8.3%
2020	2	16.7%
2021	1	8.3%
2022	1	8.3%
2023	2	16.7%
2024	2	16.7%
2025partial year	2	16.7%

Which technologies does The Council of the Queensland Institute of Medical Research patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

C07K - Peptides 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

A61B - DIAGNOSIS; SURGERY; Identification 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

The Council of the Queensland Institute of Medical Research's patent record in context - here's where to go next.

The Council of the Queensland Institute of Medical Research's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 75% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #23,523 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare The Council of the Queensland Institute of Medical Research against Tektronix Texas, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.